ANTONAZZO, IPPAZIO COSIMO
ANTONAZZO, IPPAZIO COSIMO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study
2022 Haagsma J.A.; Charalampous P.; Ariani F.; Gallay A.; Moesgaard Iburg K.; Nena E.; Ngwa C.H.; Rommel A.; Zelviene A.; Abegaz K.H.; Al Hamad H.; Albano L.; Liliana Andrei C.; Andrei T.; Antonazzo I.C.; Aremu O.; Arumugam A.; Atreya A.; Aujayeb A.; Ayuso-Mateos J.L.; Engelbert Bain L.; Banach M.; Winfried Barnighausen T.; Barone-Adesi F.; Beghi M.; Bennett D.A.; Bhagavathula A.S.; Carvalho F.; Castelpietra G.; Caterina L.; Chandan J.S.; Couto R.A.S.; Cruz-Martins N.; Damiani G.; Dastiridou A.; Demetriades A.K.; Dias-da-Silva D.; Francis Fagbamigbe A.; Fereshtehnejad S.-M.; Fernandes E.; Ferrara P.; Fischer F.; Fra.Paleo U.; Ghirini S.; Glasbey J.C.; Glavan I.-R.; Gomes N.G.M.; Grivna M.; Harlianto N.I.; Haro J.M.; Hasan M.T.; Hostiuc S.; Iavicoli I.; Ilic M.D.; Ilic I.M.; Jakovljevic M.; Jonas J.B.; Jerzy Jozwiak J.; Jurisson M.; Kauppila J.H.; Kayode G.A.; Khan M.A.B.; Kisa A.; Kisa S.; Koyanagi A.; Kumar M.; Kurmi O.P.; La-Vecchia C.; Lamnisos D.; Lasrado S.; Lauriola P.; Linn S.; Loureiro J.A.; Lunevicius R.; Madureira-Carvalho A.; Mechili E.A.; Majeed A.; Menezes R.G.; Mentis A.-F.A.; Meretoja A.; Mestrovic T.; Miazgowski T.; Miazgowski B.; Mirica A.; Molokhia M.; Mohammed S.; Monasta L.; Mulita F.; David Naimzada M.; Negoi I.; Neupane S.; Oancea B.; Orru H.; Otoiu A.; Otstavnov N.; Otstavnov S.S.; Padron-Monedero A.; Panda-Jonas S.; Pardhan S.; Patel J.; Pedersini P.; Pinheiro M.; Rakovac I.; Rao C.R.; Rawaf S.; Rawaf D.L.; Rodrigues V.; Ronfani L.; Sagoe D.; Sanmarchi F.; Santric-Milicevic M.M.; Sathian B.; Sheikh A.; Shiri R.; Shivalli S.; Dora Sigfusdottir I.; Sigurvinsdottir R.; Yurievich Skryabin V.; Aleksandrovna Skryabina A.; Smarandache C.-G.; Socea B.; Sousa R.A.R.C.; Steiropoulos P.; Tabares-Seisdedos R.; Roberto Tovani-Palone M.; Tozija F.; Van de Velde S.; Juhani Vasankari T.; Veroux M.; Violante F.S.; Vlassov V.; Wang Y.; Yadollahpour A.; Yaya S.; Sergeevich Zastrozhin M.; Zastrozhina A.; Polinder S.; Majdan M.
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system
2021 Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy
2021 Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D.; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R.
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems
2021 Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E.
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
2021 Burato S.; Leonardi L.; Antonazzo I.C.; Raschi E.; Ajolfi C.; Baraghini M.; Chiarello A.; Delmonte V.; Di Castri L.; Donati M.; Fadda A.; Fedele D.; Ferretti A.; Gabrielli L.; Gobbi S.; Lughi S.; Mazzari M.; Pieraccini F.; Renzetti A.; Russi E.; Scanelli C.; Zanetti B.; Poluzzi E.
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list?
2021 Raschi E.; Antonazzo I.C.; Poluzzi E.; De Ponti F.
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system
2020 Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E.
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study
2020 Lunghi C.; Antonazzo I.C.; Burato S.; Raschi E.; Zoffoli V.; Forcesi E.; Sangiorgi E.; Menchetti M.; Roberge P.; Poluzzi E.
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements
2020 Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E.
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution
2020 Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E.
Drug-induced Kounis syndrome: A matter of pharmacovigilance
2019 Raschi, Emanuel*; Fertonani Affini, Lorenzo; Antonazzo, Ippazio Cosimo; Diemberger, Igor; Poluzzi, Elisabetta; De Ponti, Fabrizio
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System
2019 Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; Elisa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres
2019 Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele; Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta*
LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS
2019 Lunghi, C; Antonazzo, IC; Poluzzi, E; Burato, S; Raschi, E; Forcesi, E; Sangiorgi, E; Menchetti, M; Roberge, P
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System.
2019 Raschi E, Antonazzo IC, La Placa M, Ardizzoni A, Poluzzi E, De Ponti F.
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System
2019 Raschi E.; Mazzarella A.; Antonazzo I.C.; Bendinelli N.; Forcesi E.; Tuccori M.; Moretti U.; Poluzzi E.; De Ponti F.
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study
2019 Zenesini C.; Baldin E.; Vignatelli L.; Poluzzi E.; Antonazzo I.; Calandra-Buonaura G.; Guarino M.; De Carolis P.; Cortelli P.; D'Alessandro R.
Diabetes is associated with decreased migraine risk: A nationwide cohort study
2018 Antonazzo, Ippazio Cosimo; Riise, Trond; Cortese, Marianna; Berge, Line Iden; Engeland, Anders; Bernt Fasmer, Ole; Lund, Anders; Joachim Ødegaard, Ketil; Poluzzi, Elisabetta; Bjornevik, Kjetil
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis
2018 Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis
2018 Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo; De Ponti, Fabrizio; Bégaud, Bernard
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study | Haagsma J.A.; Charalampous P.; Ariani F.; Gallay A.; Moesgaard Iburg K.; Nena E.; Ngwa C.H.; Romm...el A.; Zelviene A.; Abegaz K.H.; Al Hamad H.; Albano L.; Liliana Andrei C.; Andrei T.; Antonazzo I.C.; Aremu O.; Arumugam A.; Atreya A.; Aujayeb A.; Ayuso-Mateos J.L.; Engelbert Bain L.; Banach M.; Winfried Barnighausen T.; Barone-Adesi F.; Beghi M.; Bennett D.A.; Bhagavathula A.S.; Carvalho F.; Castelpietra G.; Caterina L.; Chandan J.S.; Couto R.A.S.; Cruz-Martins N.; Damiani G.; Dastiridou A.; Demetriades A.K.; Dias-da-Silva D.; Francis Fagbamigbe A.; Fereshtehnejad S.-M.; Fernandes E.; Ferrara P.; Fischer F.; Fra.Paleo U.; Ghirini S.; Glasbey J.C.; Glavan I.-R.; Gomes N.G.M.; Grivna M.; Harlianto N.I.; Haro J.M.; Hasan M.T.; Hostiuc S.; Iavicoli I.; Ilic M.D.; Ilic I.M.; Jakovljevic M.; Jonas J.B.; Jerzy Jozwiak J.; Jurisson M.; Kauppila J.H.; Kayode G.A.; Khan M.A.B.; Kisa A.; Kisa S.; Koyanagi A.; Kumar M.; Kurmi O.P.; La-Vecchia C.; Lamnisos D.; Lasrado S.; Lauriola P.; Linn S.; Loureiro J.A.; Lunevicius R.; Madureira-Carvalho A.; Mechili E.A.; Majeed A.; Menezes R.G.; Mentis A.-F.A.; Meretoja A.; Mestrovic T.; Miazgowski T.; Miazgowski B.; Mirica A.; Molokhia M.; Mohammed S.; Monasta L.; Mulita F.; David Naimzada M.; Negoi I.; Neupane S.; Oancea B.; Orru H.; Otoiu A.; Otstavnov N.; Otstavnov S.S.; Padron-Monedero A.; Panda-Jonas S.; Pardhan S.; Patel J.; Pedersini P.; Pinheiro M.; Rakovac I.; Rao C.R.; Rawaf S.; Rawaf D.L.; Rodrigues V.; Ronfani L.; Sagoe D.; Sanmarchi F.; Santric-Milicevic M.M.; Sathian B.; Sheikh A.; Shiri R.; Shivalli S.; Dora Sigfusdottir I.; Sigurvinsdottir R.; Yurievich Skryabin V.; Aleksandrovna Skryabina A.; Smarandache C.-G.; Socea B.; Sousa R.A.R.C.; Steiropoulos P.; Tabares-Seisdedos R.; Roberto Tovani-Palone M.; Tozija F.; Van de Velde S.; Juhani Vasankari T.; Veroux M.; Violante F.S.; Vlassov V.; Wang Y.; Yadollahpour A.; Yaya S.; Sergeevich Zastrozhin M.; Zastrozhina A.; Polinder S.; Majdan M. | 2022-01-01 | INTERNATIONAL ARCHIVES OF PUBLIC HEALTH AND COMMUNITY MEDICINE | - | 1.01 Articolo in rivista | - |
| Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system | Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi | 2021-01-01 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | - | 1.01 Articolo in rivista | adverse effect.pdf; Adverse events with sacubitrilvalsartan in the real world.pdf |
| Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy | Baldin E.; Zenesini C.; Antonazzo I.C.; Bartolomei I.; Caniatti L.; Costa M.; Curti E.; Ferraro D....; Foschi M.; Granella F.; Guareschi A.; Immovilli P.; Lugaresi A.; Malagu S.; Mancinelli L.; Montepietra S.; Mussuto V.; Neri W.; Pasquinelli M.; Pellegrino L.; Pesci I.; Poluzzi E.; Pugliatti M.; Ravasio A.; Riise T.; Salvi F.; Santangelo M.; Sireci F.; Sola P.; Strumia S.; Tsantes E.; Vignatelli L.; Vitetta F.; Viti B.; D'Alessandro R. | 2021-01-01 | NEUROEPIDEMIOLOGY | - | 1.01 Articolo in rivista | - |
| Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems | Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Ma...zzanti G.; De Ponti F.; Raschi E. | 2021-01-01 | CLINICAL NUTRITION | - | 1.01 Articolo in rivista | - |
| Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region | Burato S.; Leonardi L.; Antonazzo I.C.; Raschi E.; Ajolfi C.; Baraghini M.; Chiarello A.; Delmont...e V.; Di Castri L.; Donati M.; Fadda A.; Fedele D.; Ferretti A.; Gabrielli L.; Gobbi S.; Lughi S.; Mazzari M.; Pieraccini F.; Renzetti A.; Russi E.; Scanelli C.; Zanetti B.; Poluzzi E. | 2021-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | burato.pdf; datasheet1.doc |
| Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? | Raschi E.; Antonazzo I.C.; Poluzzi E.; De Ponti F. | 2021-01-01 | ANNALS OF THE RHEUMATIC DISEASES | - | 1.04 Replica / breve intervento (e simili) | - |
| Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system | Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E. | 2020-01-01 | ACTA DIABETOLOGICA | - | 1.01 Articolo in rivista | - |
| Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study | Lunghi C.; Antonazzo I.C.; Burato S.; Raschi E.; Zoffoli V.; Forcesi E.; Sangiorgi E.; Menchetti ...M.; Roberge P.; Poluzzi E. | 2020-01-01 | NEUROPSYCHIATRIC DISEASE AND TREATMENT | - | 1.01 Articolo in rivista | lunghi et al. 2020.pdf |
| Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements | Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Ma...zzanti G.; De Ponti F.; Raschi E. | 2020-01-01 | CLINICAL NUTRITION | - | 1.04 Replica / breve intervento (e simili) | - |
| Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution | Antonazzo I.C.; Poluzzi E.; Forcesi E.; Salvo F.; Pariente A.; Marchesini G.; De Ponti F.; Raschi E. | 2020-01-01 | ACTA DIABETOLOGICA | - | 1.04 Replica / breve intervento (e simili) | - |
| Drug-induced Kounis syndrome: A matter of pharmacovigilance | Raschi, Emanuel*; Fertonani Affini, Lorenzo; Antonazzo, Ippazio Cosimo; Diemberger, Igor; Poluzzi..., Elisabetta; De Ponti, Fabrizio | 2019-01-01 | INTERNATIONAL JOURNAL OF CARDIOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System | Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; El...isa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi | 2019-01-01 | MULTIPLE SCLEROSIS | - | 1.01 Articolo in rivista | - |
| Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres | Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele;... Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta* | 2019-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | journal.pone.0211938.pdf |
| LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS | Lunghi, C; Antonazzo, IC; Poluzzi, E; Burato, S; Raschi, E; Forcesi, E; Sangiorgi, E; Menchetti, ...M; Roberge, P | 2019-01-01 | VALUE IN HEALTH | - | 1.06 Abstract in rivista | - |
| Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System. | Raschi E, Antonazzo IC, La Placa M, Ardizzoni A, Poluzzi E, De Ponti F. | 2019-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System | Raschi E.; Mazzarella A.; Antonazzo I.C.; Bendinelli N.; Forcesi E.; Tuccori M.; Moretti U.; Polu...zzi E.; De Ponti F. | 2019-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | Raschi 2019.pdf; suppl 1.pdf; supplemento 2.pdf |
| Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study | Zenesini C.; Baldin E.; Vignatelli L.; Poluzzi E.; Antonazzo I.; Calandra-Buonaura G.; Guarino M....; De Carolis P.; Cortelli P.; D'Alessandro R. | 2019-01-01 | JOURNAL OF THE NEUROLOGICAL SCIENCES | - | 1.01 Articolo in rivista | - |
| Diabetes is associated with decreased migraine risk: A nationwide cohort study | Antonazzo, Ippazio Cosimo; Riise, Trond; Cortese, Marianna; Berge, Line Iden; Engeland, Anders; B...ernt Fasmer, Ole; Lund, Anders; Joachim Ødegaard, Ketil; Poluzzi, Elisabetta; Bjornevik, Kjetil | 2018-01-01 | CEPHALALGIA | - | 1.01 Articolo in rivista | - |
| Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis | Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo...; De Ponti, Fabrizio; Bégaud, Bernard | 2018-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
| Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis | Mouchet, Julie; Salvo, Francesco; Raschi, Emanuel; Poluzzi, Elisabetta; Antonazzo, Ippazio Cosimo...; De Ponti, Fabrizio; Bégaud, Bernard | 2018-01-01 | PHARMACOLOGICAL RESEARCH | - | 1.01 Articolo in rivista | - |